GSK-F1 (Compound F1) is an orally active PI4KA inhibitor with pIC50 values of 8.0, 5.9, 5.8, 5.9, 5.9 and 6.4 against PI4KA, PI4KB, PI3KA, PI3KB, PI3KG and PI3KD, respectively. GSK-F1 can be used for HCV infection research[1].
Molecular Weight:
603.52
Purity:
95.00
CAS Number:
[1402345-92-9]
Formula:
C27H18F5N5O4S
Target:
PI3K,PI4K
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted